154 related articles for article (PubMed ID: 236826)
1. Altered distribution and excretion of N-1-methylnicotinamide in rats with Walker 256 carcinosarcoma.
Clark BR; Murai JT; Pomeranz A; Mills PA; Halpern RM
Cancer Res; 1975 Jul; 35(7):1727-33. PubMed ID: 236826
[TBL] [Abstract][Full Text] [Related]
2. [Basic and salvage pathways of NAD biosynthesis in organs of normal rats, tumor-bearing rats and in tumors].
Reztsova VV; Filov VA; Ivin BA; Kon'kov SA; Krylova IM
Vopr Onkol; 1994; 40(1-3):68-71. PubMed ID: 7701797
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production.
Pumpo R; Sarnelli G; Spinella A; Budillon G; Cuomo R
Am J Gastroenterol; 2001 Apr; 96(4):1183-7. PubMed ID: 11316167
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
[TBL] [Abstract][Full Text] [Related]
5. Characterization of glycine N-methyltransferase from rabbit liver.
Kloor D; Karnahl K; Kömpf J
Biochem Cell Biol; 2004 Jun; 82(3):369-74. PubMed ID: 15181470
[TBL] [Abstract][Full Text] [Related]
6. [Activity of 5-alpha- and 5-beta-steroid reductases in subcellular liver structures from rats bearing Walker carcinosarcoma].
Ulinskaĭte AP; Krauialis KI; Diashrius AP
Vopr Med Khim; 1989; 35(1):77-81. PubMed ID: 2741400
[TBL] [Abstract][Full Text] [Related]
7. The relationship of the cyclic nucleotide system to inhibition of hepatic drug metabolism in Walker 256 carcinoma-bearing rats.
Olson JW; Weiner M
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):71-89. PubMed ID: 6254121
[TBL] [Abstract][Full Text] [Related]
8. Ethionine alters the urinary excretion of N1-methylnicotinamide.
Cox R
Cancer Lett; 1981 Nov; 14(2):137-42. PubMed ID: 6459158
[TBL] [Abstract][Full Text] [Related]
9. [S35 lipoic acid distribution and its effect on pyruvate dehydrogenase activity in rats with Walker carcinoma].
Karpov LM; Dvuzhil'naia ED; Savvov VI; Phan Van Thuy
Vopr Onkol; 1977; 23(10):87-90. PubMed ID: 339543
[TBL] [Abstract][Full Text] [Related]
10. [Interaction of glucocorticoids with receptors of rat liver cells during the growth of Walker carcinosarcoma].
Krauialis KI; Diashrius AP; Ulinskaĭte AP
Vopr Med Khim; 1987; 33(1):33-40. PubMed ID: 3577055
[TBL] [Abstract][Full Text] [Related]
11. Origin of increased deoxycytidine excretion into urine of rats bearing Yoshida ascites sarcoma.
Shimizu M; Fujimura S
Cancer Res; 1984 Jun; 44(6):2387-92. PubMed ID: 6722778
[TBL] [Abstract][Full Text] [Related]
12. Fluorometric assay of nicotinamide methyltransferase with a new substrate, 4-methylnicotinamide.
Sano A; Takimoto N; Takitani S
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3330-2. PubMed ID: 2534362
[TBL] [Abstract][Full Text] [Related]
13. Activation and induction of glycine N-methyltransferase by retinoids are tissue- and gender-specific.
McMullen MH; Rowling MJ; Ozias MK; Schalinske KL
Arch Biochem Biophys; 2002 May; 401(1):73-80. PubMed ID: 12054489
[TBL] [Abstract][Full Text] [Related]
14. Increased liver alanine in the tumour-bearing host. Altered levels of some enzymes involved in alanine metabolism.
Goodlad GA; Jaffray E; Loudon K; Clark CM
Biochem Int; 1990; 21(2):279-87. PubMed ID: 2403367
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide and its methyltransferase as apparent inhibitors of tRNA methylase.
Kuchino Y; Endo H
J Biochem; 1972 Apr; 71(4):719-23. PubMed ID: 4261286
[No Abstract] [Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
17. Methylation of nicotinamide in rat liver cytosol and its correlation with hepatocellular proliferation.
Hoshino J; Kühne U; Kröger H
Biochim Biophys Acta; 1982 Dec; 719(3):518-26. PubMed ID: 6217846
[TBL] [Abstract][Full Text] [Related]
18. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
19. [Thiamine and pyruvate metabolism in tumor-bearing rats].
Velichko MG; Ostrovskiĭ IuM; Trebukhina RV
Vopr Med Khim; 1978; 24(2):220-4. PubMed ID: 664448
[TBL] [Abstract][Full Text] [Related]
20. In vivo studies on the mechanism of action of the tumor inhibitor vernolepin in the Walker 256 carcinosarcoma.
Lantz CH; Larner J
Cancer Biochem Biophys; 1976 Aug; 1(5):229-38. PubMed ID: 975025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
